China's drugmakers can't sell mRNA shots but haven't quit yet [Reuters]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Reuters
new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology (300142.SZ) New Tab , opens new tab , CSPC Pharmaceutical Group (1093.HK) New Tab , opens new tab and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters. And Stemirna said in July it had halted work at a planned vaccine factory in Shanghai, citing lack of demand. Their setbacks come just as Moderna (MRNA.O) New Tab , opens new tab , which developed one of the world's first mRNA vaccines against COVID, is setting up manufacturing in Shanghai , with plans to launch up to 15 new mRNA medicines in the next five years New Tab , opens new tab and bring up to 50 candidates into clinical trials. "At the moment China's mRNA is still just taking off,"
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing the COVID-19 vaccine [Business Insider]Business Insider
- Metagenomi, Moderna terminate gene editing collaboration [Seeking Alpha]Seeking Alpha
- What to Watch in the Day Ahead - Thursday, May 2 [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks: Buy, Sell, or Hold? [Yahoo! Finance]Yahoo! Finance
- We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 5/1/24 - Form 144
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- MRNA's page on the SEC website